Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Gaze and Gait Training With rTMS

Study ID: NCT05864313
Start Date: 2026-09
End Date: 2028-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Repetitive Transcranial Magnetic Stimulation (rTMS)

Gait training

Gaze training

Sham rTMS

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

FAST for DM Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

Study ID: NCT07111065
Start Date: 2025-11-10
End Date: 2031-11-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

300

Intervention / Treatment

FISH OIL 500MG OMEGA-3 SOFT GEL MINIS

Dietary Guidelines for Americans diet

Sponsor

National Institute of Environmental Health Sciences (NIEHS)

Source: clinicaltrials.gov

Share:
Add to list

GLP-1 RA on Liver OMICS in MASLD

Study ID: NCT06982378
Start Date: 2026-01
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

GLP-1 receptor agonist

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis

Study ID: NCT07020715
Start Date: 2025-12-01
End Date: 2027-10-29
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Tolerogenic dendritic cells (tolDC)

Sponsor

University Hospital, Antwerp

Source: clinicaltrials.gov

Share:
Add to list

XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation

Study ID: NCT05275374
Start Date: 2025-12-31
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

221

Intervention / Treatment

XP-102

Trametinib

Sponsor

Xynomic Pharmaceuticals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Anifrolumab Malignancy and Serious Infections Study

Study ID: NCT07000110
Start Date: 2025-11-28
End Date: 2031-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3506

Intervention / Treatment

Anifrolumab

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Comparison of Wear Between Two Dual-mobility Acetabular Cups in Patients Undergoing Total Hip Arthroplasty

Study ID: NCT07207005
Start Date: 2025-11-15
End Date: 2036-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

96

Intervention / Treatment

do the limit

CORIN

Sponsor

GCS Ramsay Health for Teaching and Research

Source: clinicaltrials.gov

Share:
Add to list

CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)

Study ID: NCT04933422
Start Date: 2027-01
End Date: 2029-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

72

Intervention / Treatment

As a spot

Sponsor

Crimson Biopharm Inc.

Source: clinicaltrials.gov

Share:
Add to list

5-AminoLevulinic Acid Aided Resection Margins in Sarcoma

Study ID: NCT07038278
Start Date: 2025-12-01
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

20

Intervention / Treatment

5-ALA

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

Study ID: NCT05806385
Start Date: 2026-03
End Date: 2029-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Cryoablation

Cryoablation combined with PD1 Inhibitor

Sponsor

Texas Tech University Health Sciences Center

Source: clinicaltrials.gov

Share:
Add to list